ClinicalTrials.gov record
Active, not recruiting Phase 1 Interventional

PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)

ClinicalTrials.gov ID: NCT06750432

Public ClinicalTrials.gov record NCT06750432. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PMN310 in Patients With Early Alzheimer's Disease

Study identification

NCT ID
NCT06750432
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
ProMis Neurosciences, Inc
Industry
Enrollment
144 participants

Conditions and interventions

Interventions

  • PMN310 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 12, 2024
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026
Last update posted
Dec 23, 2025

2024 – 2026

United States locations

U.S. sites
22
U.S. states
10
U.S. cities
21
Facility City State ZIP Site status
Irvine Center for Clinical Research Irvine California 92614
Healthy Brain Research Long Beach California 90804
JEM Research Institute Atlantis Florida 33462
Quantum Laboratories Deerfield Beach Florida 33442
Brain Matters Research Delray Beach Florida 33445
Finlay Medical Research Miami Florida 33126
Gonzalez MD and Aswad MD Health Services, Optimus U Corp Miami Florida 33135
Renstar Medical Research Ocala Florida 34470
Charter Research Orlando Florida 32803
Alzheimer's Research and Treatment Center Stuart Florida 34997
Charter Research The Villages Florida 32162
Alzheimer's Research and Treatment Center Wellington Florida 33414
Conquest Research, LLC Winter Park Florida 32789
Columbus Memory Center, LLC Columbus Georgia 31909
CenExel iResearch, LLC Decatur Georgia 30030
Headlands Eastern MA LLC Plymouth Massachusetts 02360
Advanced Memory Research Institute of NJ Toms River New Jersey 08755
Alzheimer's Disease Research Center Albany New York 12208
Flourish Research Matthews North Carolina 28105
Neuro Behavioral Clinical Research, Inc. North Canton Ohio 44720
Keystone Clinical Studies, LLC Plymouth Meeting Pennsylvania 19462
Kerwin Medical Center Dallas Texas 75231

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06750432, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 23, 2025 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06750432 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →